Get started
Senseonics Holdings, Inc.Senseonics Holdings, Inc.Senseonics Holdings, Inc.

Senseonics Holdings, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

SENS trade ideas

SENS Long Trade Setup !🚀 🔥 📊 Breakout: SENS has broken out of a consolidation triangle with strong bullish momentum. 📈 Key Levels: Entry: $0.9054 ✅ Stop Loss (SL): $0.8476 🛡️ Target 1 (T1): $0.9839 🎯 Target 2 (T2): $1.07 🚀 🔍 Volume Confirmation: High volume adds strength to this bullish breakout. 💡 Opportunity: A great setup to ride the momentum and target potential gains! 💥 #SENS #StockTrading #TradingView #BreakoutTrade #BullishSetup #DayTrading #LongTrade #StockMarket #TechnicalAnalysis #ChartPatterns #MomentumTrading #SwingTrading #TradeSmart #RiskManagement #StockCharts #MarketAnalysis #StockWatch #ProfitableTrading #TrendTrading
AMEX:SENSLong
by ProfittoPath
"Sens Stock: Eyeing 1000% Return Potential"Sens Stock: Eyeing 38 Cents for All-Time Low Buy Opportunity Sens stock, a compelling asset in the realm of healthcare technology, is catching the attention of investors as it approaches the 38-cent mark, representing all-time lows. With the formation of a double bottom and falling wedge pattern, this potential buy opportunity could pave the way for a remarkable turnaround, offering the potential for a 1000% return to previous highs. Let's explore what Sens stock represents and delve into the promising prospects it holds. Understanding Sens Stock Sens is a healthcare technology company focused on developing innovative solutions to improve patient care and outcomes. With a portfolio that includes wearable devices, remote monitoring systems, and data analytics platforms, Sens is at the forefront of revolutionizing healthcare delivery and management. Through its cutting-edge technologies, Sens aims to empower patients, healthcare providers, and caregivers alike to make more informed decisions and enhance the quality of care. The 38-Cent Buy Opportunity As Sens stock approaches the 38-cent mark, it presents a compelling opportunity for investors to initiate positions at all-time lows. The formation of a double bottom pattern, coupled with a falling wedge, adds further conviction to this potential buy opportunity. By strategically entering the market at this critical juncture, investors may position themselves for substantial gains as the stock seeks to reverse its downtrend and embark on a new bullish trajectory. Potential for a 1000% Return The buy opportunity at 38 cents holds significant upside potential for investors eyeing a potential return to previous highs. With the formation of a double bottom and falling wedge pattern signaling a potential trend reversal, Sens stock could experience a dramatic turnaround, offering the potential for a 1000% return to previous highs. This remarkable upside underscores the attractive risk-reward profile of the investment opportunity presented by Sens stock at current levels. Conclusion: Navigating the Path Forward In conclusion, Sens stock presents a compelling buy opportunity at 38 cents, representing all-time lows and supported by the formation of a double bottom and falling wedge pattern. As investors eye the potential for a 1000% return to previous highs, prudent risk management strategies are essential to navigate the inherent volatility of the market. By carefully assessing the fundamental strengths of Sens as a healthcare technology company and monitoring technical indicators for signs of a bullish reversal, investors can position themselves strategically to capitalize on the promising prospects offered by Sens stock in the journey ahead.
AMEX:SENS
by UnknownUnicorn2319099
SENS: Short-term Bear and Medium/Long-term BullSometime this week we may see the share price of AMEX:SENS drop to $0.78. Anything lower could indicate a drop out of the trend, but if it holds, a large profit could be made moving into August. Using a combination of the following 3 scripts: 1. Advanced Price Direction Algorithm 2. DeQuex Algo 3. Moving Average Convergence Divergence If all 3 give off a green/blue/green pattern, with the MACD barely starting to show a positive evaluation when it occurs, there is a high probability that the trend will continue upwards.
AMEX:SENS
by aschnell001
Sens going too $3 by Tuesday AMEX:SENS Sensus Healthcare Inc., is a medical technology company that specializes in developing and commercializing innovative non-invasive treatment solutions for various skin conditions, including non-melanoma skin cancers. Here are a few positive aspects to consider: Innovative Treatment Solutions: Sensus Healthcare focuses on providing non-invasive and advanced treatment options for skin conditions. Their flagship product, the SRT-100™, offers a non-surgical alternative to traditional surgical procedures for treating non-melanoma skin cancers. This innovative approach can potentially provide patients with effective treatment options while minimizing the risks and complications associated with surgery. Growing Demand for Non-Invasive Treatments: The healthcare industry is witnessing an increasing demand for non-invasive treatment solutions. Patients are often seeking alternatives to surgery or more aggressive procedures. Sensus Healthcare's focus on non-invasive technologies aligns well with this growing trend and may position the company favorably in the market. Established Track Record: Sensus Healthcare has been in operation since 2010 and has developed a track record of delivering its innovative solutions to medical professionals. The company has a presence in various countries and has gained recognition within the medical community for its commitment to advancing non-invasive treatment options. Broad Applications: In addition to non-melanoma skin cancers, Sensus Healthcare's products have potential applications in treating keloids, basal cell carcinoma, and other dermatological conditions. This diversification of applications expands the market opportunity for the company and may contribute to its growth potential. Ongoing Research and Development: Sensus Healthcare continues to invest in research and development, aiming to enhance and expand its product offerings. The company's commitment to innovation and staying at the forefront of non-invasive treatment technologies could position it for future growth and increased market share.
AMEX:SENSLong
by haynow36
1